BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 19969076)

  • 1. Formation of methionine sulfoxide by peroxynitrite at position 1606 of von Willebrand factor inhibits its cleavage by ADAMTS-13: A new prothrombotic mechanism in diseases associated with oxidative stress.
    Lancellotti S; De Filippis V; Pozzi N; Peyvandi F; Palla R; Rocca B; Rutella S; Pitocco D; Mannucci PM; De Cristofaro R
    Free Radic Biol Med; 2010 Feb; 48(3):446-56. PubMed ID: 19969076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidized von Willebrand factor is efficiently cleaved by serine proteases from primary granules of leukocytes: divergence from ADAMTS-13.
    Lancellotti S; De Filippis V; Pozzi N; Oggianu L; Rutella S; Scaglione GL; Maset F; Peyvandi F; Mannucci PM; De Cristofaro R
    J Thromb Haemost; 2011 Aug; 9(8):1620-7. PubMed ID: 21605335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidation of Met1606 in von Willebrand factor is a risk factor for thrombotic and septic complications in chronic renal failure.
    De Filippis V; Lancellotti S; Maset F; Spolaore B; Pozzi N; Gambaro G; Oggianu L; Calò LA; De Cristofaro R
    Biochem J; 2012 Mar; 442(2):423-32. PubMed ID: 22091998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative modification of von Willebrand factor by neutrophil oxidants inhibits its cleavage by ADAMTS13.
    Chen J; Fu X; Wang Y; Ling M; McMullen B; Kulman J; Chung DW; López JA
    Blood; 2010 Jan; 115(3):706-12. PubMed ID: 19812385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered von Willebrand factor subunit proteolysis and multimer processing associated with the Cys2362Phe mutation in the B2 domain.
    Casonato A; De Marco L; Gallinaro L; Sztukowska M; Mazzuccato M; Battiston M; Pagnan A; Ruggeri ZM
    Thromb Haemost; 2007 Apr; 97(4):527-33. PubMed ID: 17393013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a core binding site for ADAMTS-13 in the A2 domain of von Willebrand factor.
    Wu JJ; Fujikawa K; McMullen BA; Chung DW
    Proc Natl Acad Sci U S A; 2006 Dec; 103(49):18470-4. PubMed ID: 17121983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of ADAMTS-13 activity in plasma using recombinant von Willebrand Factor A2 domain polypeptide as substrate.
    Cruz MA; Whitelock J; Dong JF
    Thromb Haemost; 2003 Dec; 90(6):1204-9. PubMed ID: 14652658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquired von Willebrand factor deficiency caused by LVAD is ADAMTS-13 and platelet dependent.
    Jilma-Stohlawetz P; Quehenberger P; Schima H; Stoiber M; Knöbl P; Steinlechner B; Felli A; Jilma B
    Thromb Res; 2016 Jan; 137():196-201. PubMed ID: 26616301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mapping of the chloride-binding site in von Willebrand factor (VWF): energetics and conformational effects on the VWF/ADAMTS-13 interaction.
    De Cristofaro R; Peyvandi F; Baronciani L; Palla R; Lavoretano S; Lombardi R; Di Stasio E; Federici AB; Mannucci PM
    J Biol Chem; 2006 Oct; 281(41):30400-11. PubMed ID: 16899464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous exposure of sites in von Willebrand factor for glycoprotein Ib binding and ADAMTS13 cleavage: studies with ristocetin.
    Chen J; Ling M; Fu X; López JA; Chung DW
    Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2625-30. PubMed ID: 22922961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shear stress-induced unfolding of VWF accelerates oxidation of key methionine residues in the A1A2A3 region.
    Fu X; Chen J; Gallagher R; Zheng Y; Chung DW; López JA
    Blood; 2011 Nov; 118(19):5283-91. PubMed ID: 21917758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of von Willebrand factor scissile bond cleavage by a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13 (ADAMTS13).
    Xiang Y; de Groot R; Crawley JT; Lane DA
    Proc Natl Acad Sci U S A; 2011 Jul; 108(28):11602-7. PubMed ID: 21705658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of ADAMTS-13 by Doxycycline Reduces von Willebrand Factor Degradation During Supraphysiological Shear Stress: Therapeutic Implications for Left Ventricular Assist Device-Associated Bleeding.
    Bartoli CR; Kang J; Restle DJ; Zhang DM; Shabahang C; Acker MA; Atluri P
    JACC Heart Fail; 2015 Nov; 3(11):860-9. PubMed ID: 26454844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure and function of snake venom toxins interacting with human von Willebrand factor.
    Matsui T; Hamako J
    Toxicon; 2005 Jun; 45(8):1075-87. PubMed ID: 15922776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathologic von Willebrand factor degradation with a left ventricular assist device occurs via two distinct mechanisms: mechanical demolition and enzymatic cleavage.
    Bartoli CR; Restle DJ; Zhang DM; Acker MA; Atluri P
    J Thorac Cardiovasc Surg; 2015 Jan; 149(1):281-9. PubMed ID: 25439775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ADAMTS-13 metalloprotease interacts with the endothelial cell-derived ultra-large von Willebrand factor.
    Dong JF; Moake JL; Bernardo A; Fujikawa K; Ball C; Nolasco L; López JA; Cruz MA
    J Biol Chem; 2003 Aug; 278(32):29633-9. PubMed ID: 12775718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnesium maintains endothelial integrity, up-regulates proteolysis of ultra-large von Willebrand factor, and reduces platelet aggregation under flow conditions.
    Dong JF; Cruz MA; Aboulfatova K; Martin C; Choi H; Bergeron AL; Martini SR; Kroll MH; Kent TA
    Thromb Haemost; 2008 Mar; 99(3):586-93. PubMed ID: 18327408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetic study of von Willebrand factor self-aggregation induced by ristocetin.
    Di Stasio E; Romitelli F; Lancellotti S; Arcovito A; Giardina B; De Cristofaro R
    Biophys Chem; 2009 Oct; 144(3):101-7. PubMed ID: 19647361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dominant von Willebrand disease type 2A groups I and II due to missense mutations in the A2 domain of the von Willebrand factor gene: diagnosis and management.
    Michiels JJ; van Vliet HH
    Acta Haematol; 2009; 121(2-3):154-66. PubMed ID: 19506362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling ADAMTS13-von Willebrand factor interaction: Implications for oxidative stress-related cardiovascular diseases and type 2A von Willebrand disease.
    Pozzi N; Lancellotti S; De Cristofaro R; De Filippis V
    Biophys Chem; 2012 Jan; 160(1):1-11. PubMed ID: 21937160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.